PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 25612618-6 2015 On the basis of the resistance profile, we were able to successfully predict that a novel resveratrol-derived COX-2 inhibitor, M8, would be active against the vemurafenib-resistant but not the vemurafenib-sensitive melanoma cells. Vemurafenib 159-170 mitochondrially encoded cytochrome c oxidase II Homo sapiens 110-115